Komboglyze 2.5mg-1000mg Tablets

Company:
AstraZeneca Pharmaceuticals (Ireland) DAC
Status:
No Recent Update
Legal Category:
Product subject to medical prescription which may be renewed (B)
Active Ingredient(s):
Metformin HydrochlorideSaxagliptin Hydrochloride
*Additional information is available within the SPC or upon request to the company

Licence number

Strength

ATC code

Dosage form

EU/1/11/731/007

2.5/1000 milligram(s)

A10BD10

Film-coated tablet

EU/1/11/731/014

2.5/1000 milligram(s)

A10BD10

Film-coated tablet

EU/1/11/731/008

2.5/1000 milligram(s)

A10BD10

Film-coated tablet

EU/1/11/731/009

2.5/1000 milligram(s)

A10BD10

Film-coated tablet

EU/1/11/731/010

2.5/1000 milligram(s)

A10BD10

Film-coated tablet

EU/1/11/731/011

2.5/1000 milligram(s)

A10BD10

Film-coated tablet

EU/1/11/731/012

2.5/1000 milligram(s)

A10BD10

Film-coated tablet

Product Notice

Supply of Komboglyze 2.5 mg/1,000 mg film coated tablets to the Irish market will be discontinued by October 2024.